Prostate Calole Cancer Treatment Caller Cancer can delay hormone treatment, study finds

A new treatment strategy tested by the UCLA investigators can provide a new hope for his Prostate Caunta Cynage after the first treatment.

This approach can help and delay the need for hormone treatment, which can have serious side effects.

The findings, which was launched at an American meeting of the Radiation Oncology (Astro) at a meeting this week, indicating that combining the targeted target medication with the radiation radiant.

New Cancer Durce FDA approval after the risk of moving forward by killing about 40%

Research focuses on men who have a way to multiply cancer when the disease is back in a few remote areas. Traditionally, this is treated with the type of stereotactic body radiation therapy Therapy Therapy Tradition, the most accurate form of radiation treatment used to treat tumors in the body.

The UCLA-LED group wants to find out if you add a PSMA radiogand treatment, a mature Ietoes medicine on the Cancer Cell, will be more effective, according to the media release.

The investigators register 92 men with the removal of prostate cancer. Part found rays alone, and the other half found new radiation for drug food.

Men found both treatments that remain cancerous in order to be added cancer for about 18 months, compared to about seven months of those who receive radiation.

Click here to sign up for our New New Weed’s Health

“This is the first random test to show that the PSMA radiooligand can be very closely to continue in the metalism,” Dr. Kishan, the guiding deputy: “Dr Ammar Kishan, the author in charge of the course, has led a digital number author.

Kishan called a job “a great example of actual interaction between the cartology and nuclear medicine.”

Click here for Fox News app

One of the biggest benefits are that patients delay the hormone treatment, according to Kishan. While this is the next common step, it often brings side effects as tiredness, the loss of bones and emotional change.

“It gives more patients before you need hormonal treatment,” Kishan said. “To avoid or delay hormonal treatment is always beneficial for the quality of life.”

Despite development, cancer ultimately returned to many patients.

“There is always an opportunity to improve,” notice Kishan. “They were still events of advancing … so there may be ways to increase the ongoing treatment.”

Much in health issues

A new drug, called 177lu-PNT2002, has already been approved for FDA – is allowed to be used in this section of the disease.

In the meantime, Kishana recommends that the men facing its prostate cancer in areas outside the prostate should “look for the market on Calogist to check the options.”